HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Abstract Recently, the global incidence of gastric/gastroesophageal junction (G/GEJ) cancer has remained high. China is also a large country with a high gastric cancer (GC) incidence rate, where the cases of GC account for 40% of all cases worldwide. More than 90% of GEJ cancers are the adenocarcino...
Saved in:
Main Authors: | Weiling Li (Author), Xiaoling Zhang (Author), Yunyi Du (Author), Ying Zhang (Author), Jing Lu (Author), Wenqing Hu (Author), Jun Zhao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastroesophageal junction adenocarcinoma. A case report
by: Marcos Félix Osorio Pagola, et al.
Published: (2010) -
Gastroesophageal junction adenocarcinoma. A case report
by: Marcos Félix Osorio Pagola, et al.
Published: (2010) -
Expression and Prognostic Value of RAD51 in Adenocarcinoma at the Gastroesophageal Junction
by: Darebai Redati, et al.
Published: (2022) -
Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report
by: Wei-Ling Li, et al.
Published: (2022) -
Biomarkers and risk factors for the early prediction of immune-related adverse events: a review
by: Ying Zhang, et al.
Published: (2022)